跳至主要内容
临床试验/NCT03853512
NCT03853512已完成4 期

Safety Assessment, Instrumental and Perceived Efficacy 21 Days of Use at Home - Bepantol Derma Spray® Dermal and Gynecological Acceptability Assessment.

Bayer1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2019年2月12日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Bayer
入组人数
33
试验地点
1
主要终点
Transepidermal water loss by TEWL probe

研究概览

简要总结

In this study, researchers want to learn more about the effect of dexpanthenol dermal spray on skin recovery after a dermatological procedure (peeling) in the intimate area of women.

After the peeling, participants will return within 3 weeks for 4 visits to the study center to investigate the skin conditions such redness, irritation, softness and possible side effects. In addition, study participants will be asked about their general acceptance of dexpanthenol dermal spray.

详细描述

The primary objective is to evaluate the efficacy of the test product to aid skin recovery after peeling in the female intima and inguinal region.

Secondary objectives comprise clinical efficacy with respect to skin hydration, softness, vitality, appearance etc. and skin recovery, consumer judgement of product performance and acceptability, and safety.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Phototypes I and II according to the Fitzpatrick scale;
  • Participants willing to have peeling in the genital area to improve the general appearance of the skin and bleaching of spots.

排除标准

  • Pathologies and/or skin injuries, such as psoriasis, sensitive skin, skin cancer, atopic dermatitis or other medical criteria to be considered at the time of evaluation
  • Hyperpigmentation in the test area that interfere with the evaluation of possible reactions (vascular malformations, scars, increase of pilosity and large amount of nevi)
  • Pathologies and/or active skin injuries (local and/or disseminated) in the evaluation area

研究组 & 干预措施

Women_Inguinal side BAY207543

Experimental

Adult women apply BAY207543 to one side of the inguinal region, and semisolid vaseline to the the opposite side after skin peeling. The area with BAY207543 will be investigated.

干预措施: BAY207543 (Bepanthol, Bepantol® Derma Spray) (Drug)

Women_Inguinal side BAY207543

Experimental

Adult women apply BAY207543 to one side of the inguinal region, and semisolid vaseline to the the opposite side after skin peeling. The area with BAY207543 will be investigated.

干预措施: Semisolid vaseline (Other)

Women_Inguinal side Vaseline

Active Comparator

Adult women apply BAY207543 to one side of the inguinal region, and semisolid vaseline to the the opposite side after skin peeling. The area with the vaseline will be investigated.

干预措施: BAY207543 (Bepanthol, Bepantol® Derma Spray) (Drug)

Women_Inguinal side Vaseline

Active Comparator

Adult women apply BAY207543 to one side of the inguinal region, and semisolid vaseline to the the opposite side after skin peeling. The area with the vaseline will be investigated.

干预措施: Semisolid vaseline (Other)

结局指标

主要结局

Transepidermal water loss by TEWL probe

时间窗: Up to 23 days

The transepidermal water loss (TEWL) is measured in g m2 h-1 with a Tewameter TM300.

次要结局

  • Skin properties of the participants(Up to 23 days)
  • Treatment satisfaction(Up to 23 days)
  • Product evaluation(Up to 23 days)
  • Number of adverse events by gynecological evaluation(Up to 23 days)
  • Severity of adverse events by dermatological evaluation(Up to 23 days)
  • Number of adverse events by dermatological evaluation(Up to 23 days)
  • Severity of adverse events by gynecological evaluation(Up to 23 days)

研究者

发起方
Bayer
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验